4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-025827
Chief Executive Officer sold 335,019 shares at an average $26.26 ($8,798,952)
- Chief Executive Officer gave up 451,189 shares (to pay taxes)
- Chief Executive Officer acquired 800,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2022-07-06 | Option exercise | +800,000 | $2.08 | $1,664,000 | 800,000 | D |
| BELANOFF JOSEPH K Chief Executive Officer | 2022-07-06 | Shares withheld for taxes | −451,189 | $26.21 | $11,825,664 | 348,811 | D |
| BELANOFF JOSEPH K Chief Executive Officer | 2022-07-06 | Sale | −279,908 | $26.27 | $7,352,008 | 2,538,218 | I |
| BELANOFF JOSEPH K Chief Executive Officer | 2022-07-07 | Sale | −55,111 | $26.26 | $1,446,945 | 2,483,107 | I |
| Derivatives | |||||||
| BELANOFF JOSEPH K Chief Executive Officer | 2022-07-06 | Option exercise · Stock option (right to buy) | +800,000 | 0 | D | ||
| Open-market sales · 335,019 sh · avg $26.26 · $8,798,952 | |||||||
Loading xslF345X03/doc4.xml…